Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

RareDR: A Drug Repositioning Approach for Rare Diseases Based on Knowledge Graph.

RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding

KG-Predict: A knowledge graph computational framework for drug repurposing

Knowledge Graphs and Explainable AI for Drug Repurposing on Rare Diseases

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing

Drug repositioning based on the heterogeneous information fusion graph convolutional network

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

HGDD - A Drug-Disease High-Order Association Information Extraction Method for Drug Repurposing via Hypergraph.

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Drug repositioning based on weighted local information augmented graph neural network

KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description

Improving Rare Disease Classification Using Imperfect Knowledge Graph

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy